Kato H, Mathis B, Shimoda T, Nakajima T, Tokunaga C, Hiramatsu Y
Medicina (Kaunas). 2025; 60(12.
PMID: 39768943
PMC: 11676985.
DOI: 10.3390/medicina60122064.
Althammer F, Roy R, Kirchner M, Lira E, Schimmer S, Charlet A
J Physiol. 2024; 602(22):6259-6280.
PMID: 39530490
PMC: 11576253.
DOI: 10.1113/JP286297.
Kirchner M, Althammer F, Campos-Lira E, Montanez J, Stern J
J Neurosci. 2024; 44(30.
PMID: 38937101
PMC: 11270521.
DOI: 10.1523/JNEUROSCI.0003-24.2024.
Dhalla N, Mota K, Elimban V, Shah A, de Vasconcelos C, Bhullar S
Cells. 2024; 13(10.
PMID: 38786079
PMC: 11119949.
DOI: 10.3390/cells13100856.
Wei D, Chen S, Xiao D, Chen R, Meng Y
Sci Rep. 2024; 14(1):7846.
PMID: 38570623
PMC: 10991295.
DOI: 10.1038/s41598-024-58632-4.
Elevated Copeptin Levels Are Associated with Heart Failure Severity and Adverse Outcomes in Children with Cardiomyopathy.
Karki K, Towbin J, Shah S, Philip R, West A, Tadphale S
Children (Basel). 2023; 10(7).
PMID: 37508636
PMC: 10377870.
DOI: 10.3390/children10071138.
Serum Chloride and Heart Failure.
Arora N
Kidney Med. 2023; 5(4):100614.
PMID: 36911181
PMC: 9995484.
DOI: 10.1016/j.xkme.2023.100614.
Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats.
Gaudard P, David H, Bideaux P, Sicard P, Cristol J, Guillon G
Int J Mol Sci. 2023; 24(2).
PMID: 36674841
PMC: 9866678.
DOI: 10.3390/ijms24021325.
The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure.
Lin Y, Tsai C, Chiang C, Kuo J, Yin W, Wen M
Acta Cardiol Sin. 2022; 38(6):700-713.
PMID: 36440253
PMC: 9692217.
DOI: 10.6515/ACS.202211_38(6).20220422A.
Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure.
Matsumoto S, Nakamura N, Konishi M, Shibata A, Kida K, Ishii S
ESC Heart Fail. 2022; 9(6):4077-4087.
PMID: 36043451
PMC: 9773655.
DOI: 10.1002/ehf2.14083.
Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.
Mu D, Cheng J, Qiu L, Cheng X
Front Cardiovasc Med. 2022; 9:901990.
PMID: 35859595
PMC: 9289206.
DOI: 10.3389/fcvm.2022.901990.
Heart Failure And Type 2 Diabetes Mellitus: Neurohumoral, Histological And Molecular Interconnections.
Ushakov A, Ivanchenko V, Gagarina A
Curr Cardiol Rev. 2022; 19(2):e170622206132.
PMID: 35718961
PMC: 10201898.
DOI: 10.2174/1573403X18666220617121144.
Metoprolol Protects Against Arginine Vasopressin-Induced Cellular Senescence in H9C2 Cardiomyocytes by Regulating the Sirt1/p53/p21 Axis.
Li Q, Huang K, Ma T, Lu S, Tang S, Wu M
Cardiovasc Toxicol. 2021; 22(2):99-107.
PMID: 34800264
PMC: 8800877.
DOI: 10.1007/s12012-021-09704-8.
Copeptin as a marker of atherosclerosis and arteriosclerosis.
Schill F, Persson M, Engstrom G, Melander O, Enhorning S
Atherosclerosis. 2021; 338:64-68.
PMID: 34785062
PMC: 7612343.
DOI: 10.1016/j.atherosclerosis.2021.10.012.
Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.
Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, Zera T
Int J Mol Sci. 2021; 22(21).
PMID: 34768894
PMC: 8584236.
DOI: 10.3390/ijms222111465.
Sodium-based osmotherapy for hyponatremia in acute decompensated heart failure.
Mohiuddin N, Frinak S, Yee J
Heart Fail Rev. 2021; 27(2):379-391.
PMID: 34767112
DOI: 10.1007/s10741-021-10124-7.
Current and emerging drug targets in heart failure treatment.
Ghionzoli N, Gentile F, Del Franco A, Castiglione V, Aimo A, Giannoni A
Heart Fail Rev. 2021; 27(4):1119-1136.
PMID: 34273070
PMC: 9197912.
DOI: 10.1007/s10741-021-10137-2.
Arginine Vasopressin as an Important Mediator of Fluctuations in the Serum Creatinine Concentration Under Decongestion Treatment in Heart Failure Patients.
Kataoka H
Circ Rep. 2021; 3(6):324-332.
PMID: 34136707
PMC: 8180366.
DOI: 10.1253/circrep.CR-21-0005.
Copeptin as a predictive marker of incident heart failure.
Schill F, Timpka S, Nilsson P, Melander O, Enhorning S
ESC Heart Fail. 2021; 8(4):3180-3188.
PMID: 34056865
PMC: 8318511.
DOI: 10.1002/ehf2.13439.
Neuroprotective Effect of Aurantio-Obtusin, a Putative Vasopressin V Receptor Antagonist, on Transient Forebrain Ischemia Mice Model.
Paudel P, Kim D, Jeon J, Park S, Seong S, Jung H
Int J Mol Sci. 2021; 22(7).
PMID: 33805177
PMC: 8037569.
DOI: 10.3390/ijms22073335.